Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay DNA+RNA Kit, 96A
The SureSelect Tumor MAP DNA+RNA Kit (G9966B) from Agilent Technologies is designed for comprehensive molecular profiling of tumor samples. This kit enables simultaneous extraction and preparation of both DNA and RNA from formalin-fixed, paraffin-embedded (FFPE) tissue samples, supporting next-generation sequencing (NGS) applications. It is optimized for high sensitivity and specificity, allowing for the detection of a broad range of genetic alterations, including mutations, fusions, and expression changes. The kit includes reagents for 96 reactions, streamlining workflow and ensuring reproducible results for cancer research and diagnostics.